NPP

UPL BROADENS BIOCONTROL PORTFOLIO WITH ACQUISITION OF NEW NATURALLY-DERIVED FUNGICIDE, OPTICHOS

Retrieved on: 
Thursday, May 5, 2022
COO, Agriculture, University, Union, Norwegian University of Life Sciences, Industry, UPL, List of life sciences, Shellfish, Farmer, NPP, NSE, Marketing communications, Acquisition, Practice of law, Renewable energy, EU

LONDON, May 5, 2022 /PRNewswire/ -- UPL Ltd. (NSE: UPL & BSE: 512070) ('UPL') announced that UPL Group has acquired OptiCHOS, a naturally derived fungicide for its Natural Plant Protection (NPP) business unit.

Key Points: 
  • LONDON, May 5, 2022 /PRNewswire/ -- UPL Ltd. (NSE: UPL & BSE: 512070) ('UPL') announced that UPL Group has acquired OptiCHOS, a naturally derived fungicide for its Natural Plant Protection (NPP) business unit.
  • OptiCHOS offers farmers a new, low-risk, residue free, and bio-degradable broad spectrum disease control solution, with low environmental and human impacts.
  • Outside the EU, UPL will identify other markets for OptiCHOS and launch registration and approval processes to make the product available to farmers.
  • This acquisition strengthens further our entire biologicals portfolio as we continue to lead on innovation in sustainable agriculture."

NASA Postdoctoral Program Seeks Early Career and Senior Scientists for Prestigious Fellowships at Its Locations Across the U.S.

Retrieved on: 
Monday, May 2, 2022
Other Manufacturing, Other Energy, LGBTQ+, Public Policy, Government, Native American, Engineering, Energy, African American, Aerospace, Science, Other Education, Manufacturing, Continuing, University, Education, Other Science, Other Consumer, Research, Other Defense, Women, Other Transport, Men, Training, Hispanic, Defense, Air, Transport, Consumer, Other Technology, Human Resources, Technology, White House, Federal Government, Professional Services, Stipend, NASA, ORAU, Education, U.S. Department of Defense Strategy for Operating in Cyberspace, NASA Headquarters, Doctor of Philosophy, Science, Program, Workforce, Health, Trial balance, NPP, U.S. Department of Energy, Office of Inspector General, Oak Ridge Institute for Science and Education, Technology, Research, Student and Exchange Visitor Program, Communications satellite, Management, Health insurance, Fiscal

NASA invites both early-career and senior scientists to explore fellowship opportunities in its postdoctoral program and share in NASA's mission to develop advancements in science, technology, aeronautics and space exploration.

Key Points: 
  • NASA invites both early-career and senior scientists to explore fellowship opportunities in its postdoctoral program and share in NASA's mission to develop advancements in science, technology, aeronautics and space exploration.
  • Learn more or apply for fellowships in the NASA Postdoctoral Program (NPP).
  • This program offers unique research opportunities to highly-talented U.S. and non-U.S. scientists to engage in ongoing NASA research projects with top scientists at a NASA Center, NASA Headquarters or at a NASA-affiliated research institute.
  • After the first year as a postdoctoral fellow, scientists interested in management may apply to the postdoctoral management program at NASA Headquarters.

LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, March 30, 2022
Inflammation, Exercise, Cisplatin, CCA, Center for Drug Evaluation and Research, NPP, Cholangiocarcinoma, NBTXR3, D, National Medical Products Administration, Forward-looking statement, FGFR2, Clinical trial, BMS, Board, DB, Research, SEC, Biotechnology, Mental Health Commission of Canada, Achievement, Food, NMPA, MBBS, New Drug Application, Ophthalmology, Center, Director, U.S. Securities and Exchange Commission, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, GLOBE, ADSS, Prescription Drug User Fee Act, Oxford Handbook of Clinical Medicine, PDUFA, Bristol Myers Squibb, CDE, R, FDA, Patient, Pharmaceutical industry

In November 2021, LianBio initiated and completed enrollment and dosing in a pharmacokinetic (PK) study of mavacamten in healthy Chinese volunteers.

Key Points: 
  • In November 2021, LianBio initiated and completed enrollment and dosing in a pharmacokinetic (PK) study of mavacamten in healthy Chinese volunteers.
  • In January 2022, LianBio initiated the Phase 3 EXPLORER-CN clinical trial of mavacamten in Chinese patients with symptomatic oHCM.
  • In October 2021, LianBio named Michael Humphries, MBBS, as Chief Scientific Advisor to guide research and development (R&D) strategy, advance the pipeline, and lead assessment of new in-licensing opportunities.
  • In October 2021, LianBio appointed Jesse Wu and Susan Silbermann to the Board of Directors.

Westinghouse, Kozloduy Strengthen Nuclear Cybersecurity

Retrieved on: 
Wednesday, February 16, 2022
Technology, Security, Other Energy, Utilities, Alternative Energy, Software, Energy, Networks, Nuclear, EMEA, Kozloduy Nuclear Power Plant, MOU, Safety, NPP, LinkedIn, Twitter, Westinghouse Electric Company, Westinghouse, Multimedia, Public, Emerson Electric, Weapon, Renewable energy, Facebook

Westinghouse Electric Sweden AB and Kozloduy Nuclear Power Plant (NPP) signed a contract for the design, delivery and installation of a cybersecurity system at the plant.

Key Points: 
  • Westinghouse Electric Sweden AB and Kozloduy Nuclear Power Plant (NPP) signed a contract for the design, delivery and installation of a cybersecurity system at the plant.
  • (Photo: Business Wire)
    I would like to highlight that maintaining a robust and effective cybersecurity system is of crucial significance for Kozloduy NPP said Nasko Mihov, Chief Executive Officer of Kozloduy NPP EAD.
  • We are proud to deliver a state-of-the-art solution to Kozloduy NPP which utilizes best-in-class cybersecurity platforms, said Tarik Choho, Westinghouse President, EMEA Operating Plant Services.
  • Our proprietary program reinforces safety and security and is implemented across the U.S. nuclear industry and meets international regulations for nuclear power plants.

ORAU Kicks off New $129.7 Million Contract to Manage NASA Postdoctoral Program with New Website for Fellowships

Retrieved on: 
Tuesday, February 1, 2022
Science, Other Science, Research, Other Education, Continuing, University, Education, Training, Stipend, NASA Headquarters, Technology, Research, NASA, Workforce, Oak Ridge Institute for Science and Education, NPP, Health, Science, Education, U.S. Department of Energy, Office of Inspector General, Trial balance, U.S. Department of Defense Strategy for Operating in Cyberspace, ORAU, Communications satellite, Management, Fiscal

ORAU assumed management of a $129.7 million contract for the NASA Postdoctoral Program (NPP) on Jan. 30 with a new website for available fellowships.

Key Points: 
  • ORAU assumed management of a $129.7 million contract for the NASA Postdoctoral Program (NPP) on Jan. 30 with a new website for available fellowships.
  • ORAU is thrilled to officially take over the management of this prestigious NASA contract that includes diverse scientific and technological fellowships offered at NASA and one-of-a-kind educational experiences that prepare future leaders for NASA and the academic community, said ORAU NPP Program Director J. Scott Miller, Ph.D.
  • In our management efforts, ORAU will support NASA's goal to build an inclusive, collaborative, open, and innovative work environment that enhances work-life balance and encourages career development for postdoctoral fellows.
  • After the first year as a postdoctoral fellow, scientists interested in management may apply to the postdoctoral management program at NASA Headquarters.

UPL swaps USD 700 Mn acquisition loan with a Sustainability loan

Retrieved on: 
Tuesday, January 4, 2022
SLL, Agriculture, Open, ESG, Sustainalytics, Acquisition, Nature, FTSE Russell, Dow Jones Sustainability Indices, UPL, Environment, Climate, NSE, SSL, Corporation, Seed, NPP, USD, Crop protection, Achievement, Sustainability, Solution, Industry, Carbon, UPL (company), Renewable energy

MUMBAI, India, Jan. 4, 2022 /PRNewswire/ -- UPL Ltd. (NSE: UPL & BSE: 512070), a global leader of crop protection products and sustainable agricultural solutions announces that it has raised a second tranche of USD700 Million sustainability linked loan (SSL) on 31stDecember 2021 with a reduction of interest cost by 35bps and an opportunity for a further reduction of 5bps on achievement of sustainability indicators agreed with the banks. The first tranche of USD750 million was raised in March and April 2021. Of the USD1.45 billion, the debt maturity for USD1.25 billion gets extended by two years to FY 2026 (against FY2024 earlier). The SLL also provides a complete pre-payment flexibility.

Key Points: 
  • UPL is on a mission to reimagine sustainability across everything it does - developing and distributing solutions that secure our future whilst safeguarding the environment.
  • The swapping of USD 1.45 billion acquisition loan to SLL with an opportunity to further reduce the interest cost is an example of our focus on sustainability and ESG providing a cost advantage.
  • UPL also recorded strong performances in the most recent Dow Jones Sustainability Index (61% improvement on 2018 score) and FTSE Russell (68% higher than industry average).
  • UPL Ltd. (NSE: UPL & BSE: 512070) is a global provider of sustainable agriculture products & solutions, with annual revenue exceeding USD5 billion.

UPL swaps USD 700 Mn acquisition loan with a Sustainability loan

Retrieved on: 
Tuesday, January 4, 2022
SLL, Agriculture, Open, ESG, Sustainalytics, Acquisition, Nature, FTSE Russell, Dow Jones Sustainability Indices, UPL, Environment, Climate, NSE, SSL, Corporation, Seed, NPP, USD, Crop protection, Achievement, Sustainability, Solution, Industry, Carbon, UPL (company), Renewable energy

UPL is on a mission to reimagine sustainability across everything it does - developing and distributing solutions that secure our future whilst safeguarding the environment.

Key Points: 
  • UPL is on a mission to reimagine sustainability across everything it does - developing and distributing solutions that secure our future whilst safeguarding the environment.
  • The swapping of USD 1.45 billion acquisition loan to SLL with an opportunity to further reduce the interest cost is an example of our focus on sustainability and ESG providing a cost advantage.
  • UPL also recorded strong performances in the most recent Dow Jones Sustainability Index (61% improvement on 2018 score) and FTSE Russell (68% higher than industry average).
  • UPL Ltd. (NSE: UPL & BSE: 512070) is a global provider of sustainable agriculture products & solutions, with annual revenue exceeding USD5 billion.

LianBio Announces Infigratinib Approved Under Special Named Patient Program for the Treatment of Cholangiocarcinoma in the Pilot Zone of Hainan Province in China

Retrieved on: 
Tuesday, December 21, 2021
Squamous cell carcinoma, GLOBE, Therapy, Physician, Bladder cancer, Inflammation, Lists of diseases, FGFR2, PRC, Bile, Cholangiocarcinoma, Neoplasm, National Medical Products Administration, Cancer, Osteochondrodysplasia, Liver, Achondroplasia, Strategic alliance, Ophthalmology, FGFR, Drug development, Biotechnology, Safety, MD, Disease, Forward-looking statement, NPP, MAPK, SHP2, U.S. Securities and Exchange Commission, National Health Commission, SEC, Population, Patient, Achievement, State Council, Chinese Academy of Engineering, Pharmaceutical industry, Medical imaging, Fine chemical, Engineering

The first cholangiocarcinoma patient in China was prescribed and treated with infigratinib at Boao Super Hospital in Mainland China, marking the first prescription of infigratinib outside of North America.

Key Points: 
  • The first cholangiocarcinoma patient in China was prescribed and treated with infigratinib at Boao Super Hospital in Mainland China, marking the first prescription of infigratinib outside of North America.
  • LianBio is committed to bringing transformative medicines to patients and physicians in China, said Yizhe Wang, Ph.D., Chief Executive of LianBio.
  • We are proud to enable early commercial access to infigratinib in Hainan Province approximately six months after the drugs first global approval.
  • LianBio in-licensed rights from BridgeBio Pharma in 2020 for infigratinib for development and commercialization in Mainland China, Hong Kong and Macau.

North America Nuclear Waste Management Systems Market, 2021-2028 - Low-Level Waste to Dominate Over the Forecast Period - ResearchAndMarkets.com

Retrieved on: 
Friday, December 17, 2021
Alternative Energy, Energy, Power plant engineering, Government, Electricity, Recycling, Hazardous waste, Waste Control Specialists, NPP, Growth, Industry, Ecology, COVID-19, Adoption, CAGR, Graphite-moderated reactor, Bechtel, Lithium, Renewable energy, Pharmaceutical industry, EnergySolutions, Veolia

Rising deployment of nuclear power plants is the major factor driving the growth of the North America nuclear waste management system market.

Key Points: 
  • Rising deployment of nuclear power plants is the major factor driving the growth of the North America nuclear waste management system market.
  • However, issues associated with nuclear waste management system being expensive hinders the growth of North America nuclear waste management system market.
  • The North America nuclear waste management system market is segmented on the bases of waste type, reactor type, disposal options, and country.
  • Based on reactor type, the North America nuclear waste management system market is segmented into pressurized water reactor, boiling water reactor, and gas cooled reactor.

Cloudflare Joins Microsoft 365 Networking Partner Program; Optimizes Cloudflare’s Zero Trust Network for Microsoft Customers

Retrieved on: 
Friday, December 10, 2021
Data Management, Security, Technology, Software, Networks, Internet, U.S. Securities and Exchange Commission, SEC, Forward-looking statement, Microsoft, Securities Exchange Act of 1934, Name, CA, Growth, NPP, Securities Act of 1933, Technology, Security (finance), Internet, Risk management

Cloudflares suite of products protect and accelerate any Internet application online without adding hardware, installing software, or changing a line of code.

Key Points: 
  • Cloudflares suite of products protect and accelerate any Internet application online without adding hardware, installing software, or changing a line of code.
  • Internet properties powered by Cloudflare have all web traffic routed through its intelligent global network, which gets smarter with every request.
  • Cloudflare may not actually achieve the plans, intentions, or expectations disclosed in Cloudflares forward-looking statements, and you should not place undue reliance on Cloudflares forward-looking statements.
  • Cloudflare, the Cloudflare logo, and other Cloudflare marks are trademarks and/or registered trademarks of Cloudflare, Inc. in the U.S. and other jurisdictions.